4th Quarter - Termination

CAPITOL HILL STRATEGIES, LLC for BIOGEN INC

Firm
Client
Income
$40,000
Expenses
—
Terminated
Dec 31, 2018

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

CMS proposed rule potential and potential legislation that includes provisions that would alter payment policies under Medicare Part B for drugs and biologics H.R. 4710, 340B PAUSE Act, establishing a moratorium on the registration of new 340B hospitals and associated sites, and requiring reporting of program data. Issues dealing with value-based contracts. H.R. 1892, Bipartisan Budget Act of 2018, provisions relating to manufacturers share of cost-sharing for Medicare beneficiaries in the donut hole phase of Part D plan coverage.

LobbyistCovered position, as disclosed
CHARLES M BRAIN Asst. to the President, Dp. Chief Staff W&M Cmte.
HEATHER MCHUGH Legislative Director, Sen. Chuck Schumer
BEAU` SCHUYLER LD-Cong. Tanner, LD-Cong. McIntyre, SA-Cong. Rose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4710 (115th), H.R. 1892 (115th)

Medical/Disease Research/Clinical Labs MED

Issues dealing with newborn screening. Issues dealing with Alzheimer's treatments. Issues dealing with the addition of Spinal Muscular Atrophy to the Recommended Uniform Screening Panel.

LobbyistCovered position, as disclosed
CHARLES M BRAIN Asst. to the President, Dp.Chief Staff W&M Cmte
HEATHER MCHUGH Legislative Director, Sen. Chuck Schumer
BEAU` SCHUYLER LD-CongTanner,LD-CongMcIntyre,SA-CongRose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.